Oncolytics Biotech Inc.
ONCY
$0.80
-$0.01-1.24%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.15% | -4.05% | 15.03% | -98.12% | -12.01% |
| Total Depreciation and Amortization | -6.25% | 111.67% | -303.11% | 275.00% | -5.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.00% | 28.95% | -34.35% | 132.89% | 123.16% |
| Change in Net Operating Assets | -4.49% | -1,720.03% | -96.12% | 540.05% | 42.99% |
| Cash from Operations | -11.59% | -11.65% | -35.27% | -17.61% | 13.25% |
| Capital Expenditure | 100.00% | -566.67% | 82.35% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -566.67% | 82.35% | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 320.99% | -- | -- |
| Issuance of Common Stock | -17.01% | 212.06% | -43.17% | 12.23% | -8.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -269.99% | 174.90% | -234.72% | 200.00% |
| Cash from Financing | -11.07% | 163.68% | -3.89% | -26.61% | -2.13% |
| Foreign Exchange rate Adjustments | 54.17% | -106.21% | 116.41% | 102.95% | -24.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -573.54% | 108.93% | -97.38% | -2,272.37% | 117.51% |